Decreased adolescent pregnancy and sexual health care during COVID-19 pandemic
February 13th 2024Adolescent pregnancy and sexual health care utilization declined during the COVID-19 pandemic, indicating significant disruptions in reproductive health services for young females, as highlighted in a recent study published in Pediatrics.
Exploring the intersection of heart health and women's health
February 12th 2024Delve into the dialogue surrounding women's cardiovascular health with Natalie Bello, MD, MPH, FACC, as she sheds light on the significance of American Heart Month and the impact of pregnancy on cardiovascular risk factors.
Study links pregnancy knowledge to opposition of abortion restriction laws
February 10th 2024Recent research suggests that a deeper understanding of pregnancy correlates with a greater likelihood of opposing legislation limiting abortion access, shedding light on the role of education in shaping public opinion on reproductive rights.
Study on PCOS and suicide risk reveals correlation
February 9th 2024A recent study revealed an 8.47-fold increased risk of suicide attempts among individuals with polycystic ovary syndrome, prompting the need for proactive mental health management in patients and improved tools for assessing health-related quality-of-life.
Study finds social inequity reduces neuraxial analgesia use in labor
February 7th 2024A recent study highlighted how racial disparities, exacerbated by structural racism, impact the administration of neuraxial analgesia during labor, underscoring the need for interventions to address social inequity in maternal health care access.
Study finds increased STI risk among transgender women with HIV
February 6th 2024A recent study found that transgender women with HIV face elevated risks of bacterial sexually transmitted infections, emphasizing the need for tailored interventions and further research to address the distinct challenges faced by this population.
Protecting HIV-positive adolescents against high-risk HPV types
February 5th 2024A recent study found that the Gardasil quadrivalent HPV vaccine effectively shields HIV-positive adolescents from high-risk HPV types 16, 18, 6, and 11, shedding light on the potential for HPV vaccination to mitigate cancer risks in this vulnerable population.
FDA clears Genius Digital Diagnostics System for cervical cancer screening
February 2nd 2024Hologic's Genius Digital Diagnostics System, the first FDA-cleared digital cytology system using AI and advanced imaging, promises improved sensitivity in detecting pre-cancerous lesions and cervical cancer cells.
Mental health risks highlighted for gender-diverse individuals
February 1st 2024A comprehensive study highlighted significant gender-related inequalities in long-term mental health conditions, emphasizing the need for improved healthcare support and inclusivity for transgender, non-binary, and gender-diverse populations.
Maternal nutrient intake and fetal growth
January 31st 2024Recent research led by David J. Rooney reveals that while folate, vitamin B12, and iron intake show no direct links to fetal parameters, lower maternal hemoglobin concentrations in late pregnancy are associated with faster fetal growth rates, larger birthweights, and increased placental weights.
Oteseconazole outperforms fluconazole in treating severe vulvovaginal candidiasis
January 31st 2024A phase 3 trial demonstrated that oteseconazole (VIVJOA; Mycovia Pharmaceuticals) capsules exhibit improved therapeutic and mycological cure rates to fluconazole for treating severe vulvovaginal candidiasis.
COVID-19 vaccination during pregnancy not linked to preterm birth
January 31st 2024A systematic review of 6 studies revealed that COVID-19 vaccination during pregnancy does not significantly increase the risk of preterm birth, providing crucial insights for public health policies and offering reassurance to healthcare providers and expectant mothers.
Metabolomics and proteomics linked to female infertility
January 30th 2024Dive into the latest research in metabolomics and proteomics, revealing potential biomarkers like fibrinogen cleavage peptides and GRAM domain-containing protein 1C, offering new avenues for diagnosis and treatment in addressing the global issue of female infertility.